Magnetic immunoprecipitation assay for the isolation of adalimumab and degradation products in preclinical biological samples磁免疫沉淀法用于分离预临床生物样本中的adalimumab及其降解产物European Journal of Pharmaceutics and BiopharmaceuticsIF4.32026-02-170OAAI
A root cause analysis to identify the mechanistic drivers of immunogenicity against the anti-VEGF biotherapeutic brolucizumabSCIENCE TRANSLATIONAL MEDICINEIF14.62023-02-0114PRE
Anti-brolucizumab immune response as one prerequisite for rare retinal vasculitis/retinal vascular occlusion adverse eventsSCIENCE TRANSLATIONAL MEDICINEIF14.62023-02-0115PRE